Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.
- Status
- COMPLETED
- Phase
- PHASE3
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Use of Bevacizumab in Trabeculectomy Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Bevacizumab in Recurrent Grade II and III Glioma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Triaging of Newly Diagnosed Breast Cancer
- Status
- WITHDRAWN
- Phase
- NA
Bendamustine and Bevacizumab for Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Therapy for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Subjects With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
LUCAS (Lucentis Compared to Avastin Study)
- Status
- COMPLETED
- Phase
- PHASE4
Bevacizumab and Endothelium Dependent Vasodilation
- Status
- COMPLETED
- Phase
- NA